Valance Washington/LinkedIn; Taras Oleksyk/EEBG; Walter Wolfsberger/The Oakland Post
Feb 9, 2026, 14:22
Valance Washington: An Evidence-Based View on Emerging Therapies for Thrombotic Disorders
Valance Washington, Professor at Oakland University, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Our latest publication — a letter in the Journal of Thrombosis and Thrombolysis offering an evidence-based view on emerging therapies for thrombotic disorders.
A quick read for clinicians and researchers navigating these challenges.”
Title: Subject: letter to the editor: platelet single-cell RNA sequencing
Authors: Valance Washington, Walter Wolfsberger, Taras Oleksyk
Read the Full Article on Journal of Thrombosis and Thrombolysis
Stay updated on all scientific advances with Hemostasis Today.
-
May 22, 2026, 13:41Ney Carter Borges: New Trial Highlights IVL as Effective Strategy for Calcified Coronary Lesions
-
May 22, 2026, 13:36Ajay Samkaria։ A Compatible Crossmatch Does Not Always Mean Complete Safety
-
May 22, 2026, 13:31Mariam Swidan: Why Hemolysis Severity Matters in G6PD Deficiency
-
May 22, 2026, 13:25Augustina Isioma Ikusemoro: Why Plasma and RBC Transfusions Follow Different Compatibility Rules
-
May 22, 2026, 13:08Anas Hamad: Thrombosis as Overlooked Clinical Challenge in APL
-
May 22, 2026, 12:29Neema Ngugi: Highlighting 6 Major Types of Anemia
-
May 22, 2026, 12:27Jacinto López Sagaseta: Solving the Structural Puzzle of FVIIa–EPCR Interaction
-
May 22, 2026, 12:25Shehab Mohamed: Exploring the Emerging Link Between JAK2 Mutations and Thoracic Aortic Aneurysms
-
May 22, 2026, 11:52Prakash W. Kamat: Highlighting the Role of Physical Activity in Hemophilia Management